United States
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
58
Total Investments
46
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Catalio Capital Management
Recent Investments (58)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Sep 2026 | |
| Series F | •••••• | Jan 2026 | |
| Late Vc | •••••• | Nov 2025 | |
| Late Vc | •••••• | Sep 2025 | |
| Series B | •••••• | May 2025 | |
•••• ••••
|
Series D | •••••• | Nov 2024 |
|
•••• ••••
|
Series D | •••••• | Nov 2024 |
|
•••• ••••
|
Series A | •••••• | Sep 2024 |
|
•••• ••••
|
Series A | •••••• | Aug 2024 |
|
•••• ••••
|
Series E | •••••• | Jul 2024 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
